Ignite Creation Date:
2024-05-06 @ 6:28 PM
Last Modification Date:
2024-10-26 @ 2:48 PM
Study NCT ID:
NCT05673928
Status:
RECRUITING
Last Update Posted:
2024-02-29
First Post:
2022-12-30
Brief Title:
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine T-DM1 in Patients with HER2-positive Metastatic Solid Tumors and Metastases to Brain TUCATEMEB
Sponsor:
Organization:
MD Anderson Cancer Center